搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Methanosaeta thermophila 50S ribosomal protein L21e (rpl21e) CSB-YP366924MNW
CSB-EP366924MNW
CSB-BP366924MNW
CSB-MP366924MNW
CSB-EP366924MNW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanosaeta thermophila UPF0200 protein Mthe_1012 (Mthe_1012) CSB-YP366925MNW
CSB-EP366925MNW
CSB-BP366925MNW
CSB-MP366925MNW
CSB-EP366925MNW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanosaeta thermophila DNA polymerase sliding clamp (pcn) CSB-YP366926MNW
CSB-EP366926MNW
CSB-BP366926MNW
CSB-MP366926MNW
CSB-EP366926MNW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanosaeta thermophila Probable 3-phosphoshikimate 1-carboxyvinyltransferase (aroA) CSB-YP366927MNW
CSB-EP366927MNW
CSB-BP366927MNW
CSB-MP366927MNW
CSB-EP366927MNW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanosaeta thermophila Ribose 1,5-bisphosphate isomerase (Mthe_1121) CSB-YP366928MNW
CSB-EP366928MNW
CSB-BP366928MNW
CSB-MP366928MNW
CSB-EP366928MNW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanosaeta thermophila Ribosomal RNA large subunit methyltransferase E (rlmE) CSB-YP366929MNW
CSB-EP366929MNW
CSB-BP366929MNW
CSB-MP366929MNW
CSB-EP366929MNW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanosaeta thermophila Threonine--tRNA ligase (thrS), partial CSB-YP366930MNW
CSB-EP366930MNW
CSB-BP366930MNW
CSB-MP366930MNW
CSB-EP366930MNW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanosaeta thermophila Geranylgeranylglyceryl phosphate synthase (Mthe_1238) CSB-YP366931MNW
CSB-EP366931MNW
CSB-BP366931MNW
CSB-MP366931MNW
CSB-EP366931MNW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanosaeta thermophila DNA polymerase II large subunit (polC), partial CSB-YP366932MNW
CSB-EP366932MNW
CSB-BP366932MNW
CSB-MP366932MNW
CSB-EP366932MNW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanosaeta thermophila Aspartate carbamoyltransferase (pyrB) CSB-YP366933MNW
CSB-EP366933MNW
CSB-BP366933MNW
CSB-MP366933MNW
CSB-EP366933MNW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanosaeta thermophila 5'-nucleotidase surE (surE) CSB-YP366934MNW
CSB-EP366934MNW
CSB-BP366934MNW
CSB-MP366934MNW
CSB-EP366934MNW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanosaeta thermophila 30S ribosomal protein S8e (rps8e) CSB-YP366935MNW
CSB-EP366935MNW
CSB-BP366935MNW
CSB-MP366935MNW
CSB-EP366935MNW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanosaeta thermophila Probable translation initiation factor IF-2 (infB), partial CSB-YP366936MNW
CSB-EP366936MNW
CSB-BP366936MNW
CSB-MP366936MNW
CSB-EP366936MNW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanosaeta thermophila Adenylosuccinate synthetase (purA) CSB-YP366937MNW
CSB-EP366937MNW
CSB-BP366937MNW
CSB-MP366937MNW
CSB-EP366937MNW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanosaeta thermophila 30S ribosomal protein S24e (rps24e) CSB-YP366938MNW
CSB-EP366938MNW
CSB-BP366938MNW
CSB-MP366938MNW
CSB-EP366938MNW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanosaeta thermophila Shikimate kinase (aroK) CSB-YP366939MNW
CSB-EP366939MNW
CSB-BP366939MNW
CSB-MP366939MNW
CSB-EP366939MNW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanosaeta thermophila Prefoldin subunit beta (pfdB) CSB-YP366940MNW
CSB-EP366940MNW
CSB-BP366940MNW
CSB-MP366940MNW
CSB-EP366940MNW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanosaeta thermophila UPF0290 protein Mthe_1386 (Mthe_1386), partial CSB-YP366941MNW1
CSB-EP366941MNW1
CSB-BP366941MNW1
CSB-MP366941MNW1
CSB-EP366941MNW1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanosaeta thermophila Putative ribosomal RNA large subunit methyltransferase H (rlmH) CSB-YP366942MNW
CSB-EP366942MNW
CSB-BP366942MNW
CSB-MP366942MNW
CSB-EP366942MNW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanosaeta thermophila 50S ribosomal protein L11P (rpl11p) CSB-YP366943MNW
CSB-EP366943MNW
CSB-BP366943MNW
CSB-MP366943MNW
CSB-EP366943MNW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>